Beautiful Virgin Islands

Tuesday, Jun 03, 2025

German expert panel says under-60s who got first AstraZeneca shot should receive DIFFERENT vaccine for second jab

German expert panel says under-60s who got first AstraZeneca shot should receive DIFFERENT vaccine for second jab

A German expert panel has recommended those who received one AstraZeneca jab should take another vaccine as their second dose, since the British jab’s side effects could be more dangerous than taking two different products.

All Germans under 60 “should be given a dose of an mRNA vaccine 12 weeks after the first vaccination instead of the second AstraZeneca … dose,” the German Government’s Standing Committee on Vaccination (STIKO) said in its latest draft recommendation published on Thursday. The jabs produced by Pfizer-BioNTech and Moderna were mentioned as possible substitutes.

“So far, no data are available on the risk of the second vaccination [with AstraZeneca],” the expert panel admits, adding that “scientific evidence” on safety and effectiveness of vaccination with two different jabs is also lacking. Still, STIKO recommended the second option for that age group.

AstraZeneca’s Vaxzevria jab can only be given to those under 60 “at the discretion of the doctor” and after a patient accepts all potential risks, the panel concluded.

The rather unorthodox advice, which implies that millions of people might potentially be forced to rely on a yet-untested vaccination strategy, comes amid serious concerns related to the British-Swedish vaccine’s potential serious side effects.

“At the moment, one can only speculate about the risk of having been vaccinated twice,” Thomas Mertens, the head of STIKO, told Der Spiegel on Thursday referring to the Vaxzevria jab.

"The obvious way out is not to try it at all but to give an mRNA vaccine as an alternative to be on the safe side."


A virologist and the former medical director of the Ulm University Hospital, Mertens also said that the results of animal experiments available so far “show that the immune response is the same” after vaccination with two different shots.

He admitted, though, that the researchers still “have to scientifically clarify” whether the protection would be just as good in humans. He also said that “there will be data on this soon.”

STIKO had announced on Tuesday that Vaxzevria can only be given to over-60s. The decision came after Germany's vaccine regulator, the Paul Ehrlich Institute, disclosed that as of March 29, the country has recorded 31 cases of cerebral sinus vein thrombosis (CSVT), nine of which resulted in death, after people took the Vaxzevria shots. CSVT is a rare form of blood clot that forms in the brain.

Mertens called the regulator’s report a “very clear signal” which STIKO had to react to. The report also suggested that people under 60 appear more likely to be affected by this particular side effect. He also cited the data provided by Norway that suggested the jab provoked CSVT “at a ratio of 1 to 25,000 vaccinations.”

Some 2.8 million Germans already received their first Vaxzevria shot. Only around 2,000 people took the second shot too, according to German media. According to official figures, women under the age of 70 make up two-thirds of those vaccinated with the AstraZeneca drug. Some reports attribute this statistic to a fact that nurses were one of the primary groups to get it.

Earlier, dozens of nations in Europe and beyond temporarily halted the use of the vaccine following the reports of fatal blood clotting. Both the European Medicines Agency (EMA) and the World Health Organization have both said that they consider Vaxzevria safe to use, however, with benefits outweighing the risks of rare side-effects.

Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Dutch government falls as far-right leader Wilders quits coalition
Harvard Urges US to Unfreeze Funds for Public Health Research
Businessman Mauled by Lion at Luxury Namibian Lodge
Researchers Consider New Destinations Beyond the U.S.
53-Year-Old Doctor Claims Biological Age of 23
Trump Struggles to Secure Trade Deals With China and Europe
Russia to Return 6,000 Corpses Under Ukraine Prisoner Swap Deal
Microsoft Lays Off Hundreds More Amid Restructuring
Harvey Weinstein’s Publicist Embraces Notoriety
Macron and Meloni Seek Unity Despite Tensions
Trump Administration Accused of Obstructing Deportation Cases
Newark Mayor Sues Over Arrest at Immigration Facility
Center-Left Candidate Projected to Win South Korean Presidency
Trump’s Tariffs Predicted to Stall Global Economic Growth
South Korea’s President-Elect Expected to Take Softer Line on Trump and North Korea
Trump’s China Strategy Remains a Geopolitical Puzzle
Ukraine Executes Long-Range Drone Strikes on Russian Airbases
Conservative Karol Nawrocki wins Poland’s presidential election
Study Identifies Potential Radicalization Risk Among Over One Million Muslims in Germany
Good news: Annalena Baerbock Elected President of the UN General Assembly
Apple Appeals EU Law Over User Data Sharing Requirements
South Africa: "First Black Bank" Collapses after Being Looted by Owners
Poland will now withdraw from the EU migration pact after pro-Trump nationalist wins Election
"That's Disgusting, Don’t Say It Again": The Trump Joke That Made the President Boil
Trump Cancels NASA Nominee Over Democratic Donations
Paris Saint-Germain's Greatest Triumph Is Football’s Lowest Point
OnlyFans for Sale: From Lockdown Lifeline to Eight-Billion-Dollar Empire
Mayor’s Security Officer Implicated | Shocking New Details Emerge in NYC Kidnapping Case
Hegseth Warns of Potential Chinese Military Action Against Taiwan
OPEC+ Agrees to Increase Oil Output for Third Consecutive Month
Jamie Dimon Warns U.S. Bond Market Faces Pressure from Rising Debt
Turkey Detains Istanbul Officials Amid Anti-Corruption Crackdown
Taylor Swift Gains Ownership of Her First Six Albums
Bangkok Ranked World's Top City for Remote Work in 2025
Satirical Sketch Sparks Political Spouse Feud in South Korea
Indonesia Quarry Collapse Leaves Multiple Dead and Missing
South Korean Election Video Pulled Amid Misogyny Outcry
Asian Economies Shift Away from US Dollar Amid Trade Tensions
Netflix Investigates Allegations of On-Set Mistreatment in K-Drama Production
US Defence Chief Reaffirms Strong Ties with Singapore Amid Regional Tensions
Vietnam Faces Strategic Dilemma Over China's Mekong River Projects
Malaysia's First AI Preacher Sparks Debate on Islamic Principles
White House Press Secretary Criticizes Harvard Funding, Advocates for Vocational Training
France to Implement Nationwide Smoking Ban in Outdoor Spaces Frequented by Children
Meta and Anduril Collaborate on AI-Driven Military Augmented Reality Systems
Russia's Fossil Fuel Revenues Approach €900 Billion Since Ukraine Invasion
U.S. Justice Department Reduces American Bar Association's Role in Judicial Nominations
U.S. Department of Energy Unveils 'Doudna' Supercomputer to Advance AI Research
U.S. SEC Dismisses Lawsuit Against Binance Amid Regulatory Shift
Alcohol Industry Faces Increased Scrutiny Amid Health Concerns
×